The data shown below were collected from the profiles of 14 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Title |
Clinical Effectiveness of Intravitreal Therapy With Ranibizumab vs Aflibercept vs Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion
|
---|---|
Published in |
JAMA Ophthalmology, November 2019
|
DOI | 10.1001/jamaophthalmol.2019.3305 |
Pubmed ID | |
Authors |
Philip Hykin, A. Toby Prevost, Joana C. Vasconcelos, Caroline Murphy, Joanna Kelly, Jayashree Ramu, Barry Hounsome, Yit Yang, Simon P Harding, Andrew Lotery, Usha Chakravarthy, Sobha Sivaprasad |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 4 | 29% |
United States | 2 | 14% |
Brazil | 1 | 7% |
Saudi Arabia | 1 | 7% |
Unknown | 6 | 43% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 8 | 57% |
Practitioners (doctors, other healthcare professionals) | 4 | 29% |
Scientists | 2 | 14% |
Mendeley readers
The data shown below were compiled from readership statistics for 93 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 93 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 9 | 10% |
Student > Master | 9 | 10% |
Student > Postgraduate | 8 | 9% |
Student > Doctoral Student | 8 | 9% |
Other | 7 | 8% |
Other | 17 | 18% |
Unknown | 35 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 39 | 42% |
Nursing and Health Professions | 4 | 4% |
Biochemistry, Genetics and Molecular Biology | 3 | 3% |
Pharmacology, Toxicology and Pharmaceutical Science | 3 | 3% |
Computer Science | 2 | 2% |
Other | 9 | 10% |
Unknown | 33 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 September 2023.
All research outputs
#1,755,417
of 25,385,509 outputs
Outputs from JAMA Ophthalmology
#889
of 6,643 outputs
Outputs of similar age
#37,155
of 374,997 outputs
Outputs of similar age from JAMA Ophthalmology
#27
of 96 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 6,643 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.7. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 374,997 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 71% of its contemporaries.